Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.

Literature DB >> 29025763

One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.

Michael A Portman¹, Sadeep Shrestha².

Abstract

Entities: Chemical Disease Gene Mutation Species

Keywords: Editorials; allergy and immunology; humans; immune system; mucocutaneous lymph node syndrome

Mesh：

Substances：

Year: 2017 PMID： 29025763 PMCID： PMC5661947 DOI： 10.1161/CIRCGENETICS.117.001917

Source DB: PubMed Journal: Circ Cardiovasc Genet ISSN： 1942-3268

× No keyword cloud information.

19 in total

1. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

Authors: Chiea Chuen Khor; Sonia Davila; Willemijn B Breunis; Yi-Ching Lee; Chisato Shimizu; Victoria J Wright; Rae S M Yeung; Dennis E K Tan; Kar Seng Sim; Jie Jin Wang; Tien Yin Wong; Junxiong Pang; Paul Mitchell; Rolando Cimaz; Nagib Dahdah; Yiu-Fai Cheung; Guo-Ying Huang; Wanling Yang; In-Sook Park; Jong-Keuk Lee; Jer-Yuarn Wu; Michael Levin; Jane C Burns; David Burgner; Taco W Kuijpers; Martin L Hibberd
Journal: Nat Genet Date: 2011-11-13 Impact factor: 38.330

2. A genome-wide association study identifies three new risk loci for Kawasaki disease.

Authors: Yoshihiro Onouchi; Kouichi Ozaki; Jane C Burns; Chisato Shimizu; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Hiroyuki Suzuki; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Yoichi Suzuki; Kumi Yasukawa; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yuji Murata; Kumiko Sasago; Atsushi Takahashi; Naoyuki Kamatani; Michiaki Kubo; Tatsuhiko Tsunoda; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal: Nat Genet Date: 2012-03-25 Impact factor: 38.330

Review 3. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies.

Authors: Y M Deo; R F Graziano; R Repp; J G van de Winkel
Journal: Immunol Today Date: 1997-03

4. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.

Authors: Y Onouchi; Y Suzuki; H Suzuki; M Terai; K Yasukawa; H Hamada; T Suenaga; T Honda; A Honda; H Kobayashi; T Takeuchi; N Yoshikawa; J Sato; S Shibuta; M Miyawaki; K Oishi; H Yamaga; N Aoyagi; S Iwahashi; R Miyashita; Y Murata; R Ebata; K Higashi; K Ozaki; K Sasago; T Tanaka; A Hata
Journal: Pharmacogenomics J Date: 2011-10-11 Impact factor: 3.550

5. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

Authors: A Samuelsson; T L Towers; J V Ravetch
Journal: Science Date: 2001-01-19 Impact factor: 47.728

6. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.

Authors: Jane W Newburger; Lynn A Sleeper; Brian W McCrindle; L LuAnn Minich; Welton Gersony; Victoria L Vetter; Andrew M Atz; Jennifer S Li; Masato Takahashi; Annette L Baker; Steven D Colan; Paul D Mitchell; Gloria L Klein; Robert P Sundel
Journal: N Engl J Med Date: 2007-02-15 Impact factor: 91.245

7. Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease.

Authors: Martin Prince Alphonse; Trang T Duong; Chisato Shumitzu; Truong Long Hoang; Brian W McCrindle; Alessandra Franco; Stéphane Schurmans; Dana J Philpott; Martin L Hibberd; Jane Burns; Taco W Kuijpers; Rae S M Yeung
Journal: J Immunol Date: 2016-09-30 Impact factor: 5.422

8. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

Authors: Adriana H Tremoulet; Sonia Jain; Preeti Jaggi; Susan Jimenez-Fernandez; Joan M Pancheri; Xiaoying Sun; John T Kanegaye; John P Kovalchin; Beth F Printz; Octavio Ramilo; Jane C Burns
Journal: Lancet Date: 2014-02-24 Impact factor: 79.321

9. High-dose intravenous gammaglobulin for Kawasaki disease.

Authors: K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal: Lancet Date: 1984-11-10 Impact factor: 79.321

10. Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.

Authors: Ho-Chang Kuo; Henry Sung-Ching Wong; Wei-Pin Chang; Ben-Kuen Chen; Mei-Shin Wu; Kuender D Yang; Kai-Sheng Hsieh; Yu-Wen Hsu; Shih-Feng Liu; Xiao Liu; Wei-Chiao Chang
Journal: Circ Cardiovasc Genet Date: 2017-10

3 in total